Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

BACKGROUND: Characterized by aggressive proliferation, extensive stromal fibrosis, and resulting drug resistance, peritoneal dissemination in gastric cancer remains associated with poor prognosis. Interaction between cancer and stromal cells accelerates tumor progression via epithelial–mesenchymal t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Manag Res
Asıl Yazarlar: Kurata, Toru, Fushida, Sachio, Kinoshita, Jun, Oyama, Katsunobu, Yamaguchi, Takahisa, Okazaki, Mitsuyoshi, Miyashita, Tomoharu, Tajima, Hidehiro, Ninomiya, Itasu, Ohta, Tetsuo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6101023/
https://ncbi.nlm.nih.gov/pubmed/30147370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S167846
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller